Clinical Presentation of a Patient with a Congenital Disorder of Glycosylation, Type IIs (ATP6AP1), and Liver Transplantation
International Journal of Molecular Sciences · 18.04.2023 · 24 (8) · 7449
DOI: 10.3390/ijms24087449 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.04.2023. Verfasst von Natalia Semenova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, 115522 Moscow, Russia. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Liver Transplantation, Vacuolar Proton-Translocating ATPases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The congenital disorder of glycosylation type IIs (ATP6AP1-CDG; OMIM# 300972) is a rare X-linked recessive complex syndrome characterized by liver dysfunction, recurrent bacterial infections, hypogammaglobulinemia, and defective glycosylation of serum proteins. Here, we examine the case of a 1-year-old male patient of Buryat origin, who presented with liver dysfunction. At the age of 3 months, he was hospitalized with jaundice and hepatosplenomegaly. Whole-exome sequencing identified the ATP6AP1 gene missense variant NM_001183.6:c.938A>G (p.Tyr313Cys) in the hemizygous state, which was previously reported in a patient with immunodeficiency type 47. At the age of 10 months, the patient successfully underwent orthotopic liver transplantation. After the transplantation, the use of Tacrolimus entailed severe adverse effect (colitis with perforation). Replacing Tacrolimus with Everolimus led to improvement. Previously reported patients demonstrated abnormal N- and O-glycosylation, but these data were collected without any specific treatment. In contrast, in our patient, isoelectric focusing (IEF) of serum transferrin was performed only after the liver transplant and showed a normal IEF pattern. Thus, liver transplantation could be a curative option for patients with ATP6AP1-CDG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for Medical Genetics, 115522 Moscow, Russia.
- National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after V.I. Kulakov, Ministry of Health of the Russian Federation, 127994 Moscow, Russia.
- Department of Neonatology, I.M. Sechenov First Moscow State Medical University, 119435 Moscow, Russia.
- Federal Research Center of Nutrition and Biotechnology, 109240 Moscow, Russia.
ORCID-Profile: Natalia Semenova, Olga Shatokhina, Olga Shchagina, Andrey Marakhonov, Anna Degtyareva
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Semenova, N., Shatokhina, O., Shchagina, O., Kamenec, E., Marakhonov, A., Degtyareva, A., Taran, N., & Strokova, T. (2023). Clinical Presentation of a Patient with a Congenital Disorder of Glycosylation, Type IIs (ATP6AP1), and Liver Transplantation. International Journal of Molecular Sciences, 24(8), 7449. https://doi.org/10.3390/ijms24087449
Vancouver
Semenova N, Shatokhina O, Shchagina O, Kamenec E, Marakhonov A, Degtyareva A, et al. Clinical Presentation of a Patient with a Congenital Disorder of Glycosylation, Type IIs (ATP6AP1), and Liver Transplantation. International Journal of Molecular Sciences. 2023;24(8):7449. doi:10.3390/ijms24087449
BibTeX
@article{Semenova2023,
author = {Semenova, Natalia and Shatokhina, Olga and Shchagina, Olga and Kamenec, Elena and Marakhonov, Andrey and Degtyareva, Anna and Taran, Natalia and Strokova, Tatiana},
title = {Clinical Presentation of a Patient with a Congenital Disorder of Glycosylation, Type IIs (ATP6AP1), and Liver Transplantation},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7449},
doi = {10.3390/ijms24087449}
}
EUVIMED